Patients with colon cancer who still have cancer cells in their blood after surgery may improve their survival odds with ...

A data analysis from a randomized clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham ...

Evidence has since emerged suggesting that anti-inflammatory drugs might benefit some patients with colon cancer, but not others. One possibility for this is that patients who have a blood test ...

DelveInsight's Inflammatory Bowel disease market Report provides comprehensive insights into the epidemiology and market dynamics across the 7MM. LAS VEGAS , NV, UNITED STATES, January 30, 2025 ...

What sets NiMe apart from other diets is that it is dominated by vegetables (such as leafy greens) and legumes (such as beans ...

Recent research indicates that colon cancer patients with circulating tumor DNA post-surgery may improve their survival likelihood with daily celecoxib use. Celecoxib, a COX-2 inhibitor, significantly ...

The Alliance for Clinical Trials in Oncology today announced the results of a data analysis from a randomized phase III clinical trial involving patients with stage III colon cancer, which found that ...

Experts hope to create a blood test to see which patients with inflammatory bowel disease are most at risk of bowel cancer.

Colon cancer is the third leading cause of cancer-related deaths worldwide, posing a significant global health challenge.